Madrigal Pharmaceuticals Inc (MDGL) Event Aug. 04, 2022, 00:00 UTC (47% Neutral) MADRIGAL PHARMACEUTICALS, INC. (MDGL) Reports 108% Loss Increase for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:50 a.m. 🏢 Madrigal Pharmaceuticals Inc (MDGL) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-128.20M $-61.65M $-66.55M -107.94% 📈 Total Assets $273.33M $216.39M $56.94M +26.31% 📈 Total Liabilities $77.22M $132.86M $-55.63M -41.87% 📈 Stockholders' Equity $270.65M $-539.66M $810.31M +150.15% 📈 Operating Income/Loss $-114.72M $-127.86M $13.14M +10.28% 📉 Earningspersharebasic $-7.05 $-7.50 $0.45 +6.00% 📈 Earningspersharediluted $-7.05 $-7.50 $0.45 +6.00% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Madrigal Pharmaceuticals Inc (MDGL) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document